AspirinAnticoagulantsLupus Coagulation InhibitorWarfarinBlood CoagulationPlatelet Aggregation InhibitorsProthrombin TimeProtein CHeparinPartial Thromboplastin TimeRodenticidesAcenocoumarolFactor XaPhenindioneAntithrombinsHemorrhageBlood Coagulation Tests4-HydroxycoumarinsThromboembolismThrombosisInternational Normalized RatioThrombin TimeAnti-Inflammatory Agents, Non-SteroidalHeparin, Low-Molecular-WeightProtein SBlood Coagulation Factorsbeta-AlanineThrombomodulinProthrombinThrombinAntiphospholipid SyndromeVitamin KFibrinolytic AgentsAntibodies, AntiphospholipidThrombophlebitisVenous ThrombosisAdministration, OralTiclopidinePhenprocoumonAntithrombin IIIAntibodies, AnticardiolipinPlatelet AggregationThrombophiliaVenous ThromboembolismBlood Coagulation DisordersPulmonary EmbolismThromboxane B2Atrial FibrillationBlood PlateletsHirudinsSalicylatesThromboplastinHeparin AntagonistsHemostasisFactor XCyclooxygenase InhibitorsPlatelet Function TestsDrug Therapy, CombinationFactor VThiophenesEnoxaparinCoagulantsbeta 2-Glycoprotein IDicumarolPipecolic AcidsStrokeActivated Protein C ResistanceFactor VaBleeding TimeRodent ControlRisk FactorsTreatment OutcomeDose-Response Relationship, DrugTime FactorsPlatelet ActivationPyridonesBenzimidazolesDermatan SulfateDalteparinVitamin K Epoxide ReductasesProtein C DeficiencyGastrointestinal HemorrhageRecurrenceProspective StudiesHeparin Cofactor IIPostoperative HemorrhageProtein S DeficiencyHematomaDrug MonitoringCardiolipinsSodium SalicylateAntithrombin III DeficiencyCoumarinsDrug InteractionsEmbolismFollow-Up StudiesLupus Erythematosus, SystemicSea CucumbersMyocardial InfarctionCerebral Hemorrhage